Display options
Share it on

Small GTPases. 2011 Mar;2(2):95-98. doi: 10.4161/sgtp.2.2.15378.

Regulation of Toll and Toll-like receptor signaling by the endocytic pathway.

Small GTPases

Viktor K Lund, Robert Delotto

Affiliations

  1. Department of Biology; University of Copenhagen; Denmark.

PMID: 21776409 PMCID: PMC3136911 DOI: 10.4161/sgtp.2.2.15378

Abstract

The Toll/TLR receptor family plays a central role in both vertebrate and insect immunity, driving the activation of humoral immunity in response to pathogens. In Drosophila, Toll is also responsible for directing the formation of the Dorsal/NFkappaB gradient specifying dorsoventral patterning of the embryo. Two recent studies have revealed that endocytosis and elements of the molecular machinery governing endosomal progression are required for Drosophila Toll signaling in development and immunity. We demonstrated that Toll is not only present at the plasma membrane but also in a Rab5(+) early endosomal compartment in the embryo and that the distribution of constitutively active Toll(10B) is shifted towards endosomes. Localized inhibition of Rab5 function on the ventral side leads to a reduction of nuclear Dorsal levels, while locally increasing Rab5 function leads to potentiation of signaling. Independently, another laboratory identified the endosomal protein Mop as a potentiator of Toll signaling in Drosophila cell culture and fat-body tissue. Mop functions together with the ESCRT 0 component, Hrs, previously reported to stimulate endosomal progression and the signaling ability of internalized EGFR. We discuss these studies and briefly summarize the most significant findings concerning the role of intracellular localization and trafficking in mammalian TLR function.

References

  1. Nat Cell Biol. 2005 Aug;7(8):758-65 - PubMed
  2. Nature. 2008 Dec 4;456(7222):658-62 - PubMed
  3. Curr Biol. 2006 Jun 20;16(12):1183-93 - PubMed
  4. J Cell Biol. 2003 Aug 4;162(3):435-42 - PubMed
  5. Nat Rev Immunol. 2009 Aug;9(8):535-42 - PubMed
  6. J Cell Sci. 2007 Oct 1;120(Pt 19):3457-64 - PubMed
  7. Nature. 2008 Mar 13;452(7184):234-8 - PubMed
  8. Nat Immunol. 2008 Dec;9(12):1407-14 - PubMed
  9. Development. 2008 Jun;135(11):1913-22 - PubMed
  10. J Cell Biol. 2006 Apr 10;173(1):95-106 - PubMed
  11. Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10520-5 - PubMed
  12. J Cell Biol. 2009 May 4;185(3):493-502 - PubMed
  13. Dev Cell. 2006 Jun;10(6):839-50 - PubMed
  14. Science. 2006 Oct 13;314(5797):308-12 - PubMed
  15. Nat Cell Biol. 2002 May;4(5):394-8 - PubMed
  16. Mol Biol Cell. 2007 Oct;18(10):3952-65 - PubMed
  17. Nat Immunol. 2010 May;11(5):373-84 - PubMed
  18. J Cell Sci. 2008 May 15;121(Pt 10):1727-38 - PubMed
  19. J Biol Chem. 2008 May 23;283(21):14629-35 - PubMed
  20. Dev Biol. 2007 Jul 1;307(1):53-61 - PubMed
  21. Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):18028-33 - PubMed
  22. Mol Cell Biol. 2003 Nov;23(22):7982-91 - PubMed
  23. Nat Immunol. 2008 Apr;9(4):361-8 - PubMed
  24. Nature. 2010 Apr 8;464(7290):864-9 - PubMed
  25. Curr Biol. 2005 Nov 8;15(21):R887-99 - PubMed
  26. Histol Histopathol. 2010 Jan;25(1):99-112 - PubMed
  27. Nat Immunol. 2006 Feb;7(2):156-64 - PubMed
  28. J Exp Med. 2007 Nov 26;204(12):2963-76 - PubMed
  29. Dev Cell. 2006 Jan;10(1):45-55 - PubMed
  30. Nat Immunol. 2004 Feb;5(2):190-8 - PubMed
  31. PLoS One. 2010 Apr 21;5(4):e10245 - PubMed
  32. J Cell Biol. 2008 Feb 25;180(4):755-62 - PubMed
  33. Cell. 2002 Jan 25;108(2):261-9 - PubMed
  34. EMBO Rep. 2002 Jul;3(7):666-73 - PubMed
  35. Proc Natl Acad Sci U S A. 2010 May 4;107(18):8322-7 - PubMed
  36. J Cell Physiol. 2006 Oct;209(1):21-43 - PubMed
  37. Development. 2001 Jun;128(12):2309-19 - PubMed
  38. Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6262-7 - PubMed

Publication Types